A Phase 2 Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Single Intrathecal Preoperative Administration of Brivoligide Injection in Patients With a Pain Catastrophizing Scale Score ≥16 Undergoing Unilateral Total Knee Arthroplasty
Status: Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 14 Nov 2019
Price : $35 *
At a glance
- Drugs Brivoligide (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Adynxx
- 14 Nov 2019 According to an Adynxx media release, the company plans to initiate this study in first quarter of 2020 with the topline data from this first study expected in fourth quarter of 2020.
- 01 Jul 2019 Planned End Date changed from 24 Feb 2020 to 15 Jun 2020.
- 01 Jul 2019 Planned primary completion date changed from 17 Feb 2020 to 1 Jun 2020.